Sheue Fang Shih
Senior Director, Product Development
Pharma
Taiwan Liposome Company
Taiwan
Biography
Dr. Shih has more than 15 years of experience in drug development. Her research focuses on the development of protein drug delivery, antibody discovery and targeted drug delivery with immunoliposomes. Dr. Shih joined TLC in 2002. In her role as Manager/Project Leader, Dr. Shih led various research and development programs in areas of retinal diseases and arthritis and received IND approvals from the U.S. FDA as well as Taiwan FDA. Her current role specializes in drug development, product development strategy, non-clinical and clinical operations as well as planning. Dr. Shih has authored a number of scientific publications and is the inventor of a novel anti-VEGF antibody and several drug delivery patents.
Research Interest
Pharma
